Page last updated: 2024-12-05
1,5-diaminoanthraquinone
Description
1,5-Diaminoanthraquinone is a key intermediate in the synthesis of various dyes, pigments, and organic colorants. It is typically produced by the reduction of 1,5-dinitroanthraquinone. Research focuses on developing sustainable and environmentally friendly methods for its synthesis. 1,5-Diaminoanthraquinone exhibits antioxidant properties and has been studied for its potential applications in medical fields. Its importance stems from its versatile nature as a building block for various organic compounds with diverse applications.'
1,5-diaminoanthraquinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 8513 |
CHEMBL ID | 90387 |
SCHEMBL ID | 64318 |
MeSH ID | M0516540 |
Synonyms (57)
Synonym |
BIDD:GT0325 |
1,5-diamino-anthraquinone |
CHEMBL90387 |
1,5-daa [russian] |
9,10-anthracenedione, 1,5-diamino- |
1,5-diaminoanthrachinon [czech] |
einecs 204-947-2 |
nsc 7213 |
ccris 5609 |
anthraquinone, 1,5-diamino- |
smoke red f |
1,5-diamino-9,10-anthraquinone |
brn 2215892 |
nsc 63791 |
UPCMLD0ENAT5883787:001 |
1,5-diaminoanthrachinon |
anthraquinone,5-diamino- |
wln: l c666 bv ivj dz kz |
129-44-2 |
1,5-anthraquinonyldiamine |
1,5-daa |
c.i. disperse red ii |
1,5-diaminoanthraquinone |
nsc-7213 |
9, 1,5-diamino- |
nsc7213 |
NCI60_041509 |
nsc63791 |
nsc-63791 |
anthraquinone, 1,5-diamino |
PRESTWICK_161 |
inchi=1/c14h10n2o2/c15-9-5-1-3-7-11(9)14(18)8-4-2-6-10(16)12(8)13(7)17/h1-6h,15-16h |
1,5-diaminoanthraquinone, technical grade, 85% |
NCIOPEN2_002796 |
STK874274 |
1,5-diaminoanthracene-9,10-dione |
D1268 |
AKOS000119638 |
A805940 |
unii-3zxx3hk358 |
3zxx3hk358 , |
FT-0606948 |
nsc-507213 |
SCHEMBL64318 |
1,5-diamino-9,10-dihydroanthracene-9,10-dione |
DTXSID1059602 |
1,5-diaminoanthra-9,10-quinone # |
W-108362 |
mfcd00001226 |
1,5-diaminoanthraquinone, 97% |
Z57379624 |
EN300-18214 |
Q27258270 |
D89823 |
111641-58-8 |
SY048855 |
CS-0010166 |
Protein Targets (7)
Inhibition Measurements
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.6003 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.6306 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0006 | 1.5257 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.7472 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.7411 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.7411 | 10.0000 | AID144609; AID144610 |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 (µMol) | 330.5000 | 0.0007 | 1.7411 | 10.0000 | AID144609; AID144610 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Ceullar Components (2)
Process | via Protein(s) | Taxonomy |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) |
endoplasmic reticulum membrane | Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) |
plasma membrane | Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 24.68
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 24.68 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 5.12 (4.65) | Search Engine Demand Index | 23.28 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |